Frequency and Extent of Multivessel Coronary Artery Disease in Patients with Non St-Segment Elevation Myocardial Infarction (Nstemi)With Raised Cardiac Troponin-T (CTNT): Extent of Multivessel Coronary Artery Disease in Patients with NSTEMI

Muhammad  Salman; Muhammad  Abbas Khan; Muhammad  Yousaf; Inam-U-llah .; Mumtaz  Hussain; Adeel  Sarfraz

doi:10.54393/pjhs.v4i01.508

Authors

Muhammad Salman Department of Interventional Cardiology, Medical Teaching Institution Hayatabad Medical Complex Peshawar, Pakistan
Muhammad Abbas Khan Department of Interventional Cardiology, Medical Teaching Institution Hayatabad Medical Complex Peshawar, Pakistan
Muhammad Yousaf Department of Biochemistry, Bahauddin Zakariya University, Multan, Pakistan
Inam-U-llah . Department of Food Sciences, The University of Haripur, KPK, Pakistan
Mumtaz Hussain Department of Anatomy & Histology, Faculty of Veternary and Animal Sciences, The Islamia University of Bahawalpur, Pakistan
Adeel Sarfraz Department of Anatomy & Histology, Faculty of Veternary and Animal Sciences, The Islamia University of Bahawalpur, Pakistan

DOI:

https://doi.org/10.54393/pjhs.v4i01.508

Keywords:

ST-Segment Elevation, Multi-Vessel Coronary Artery Disease, Troponin T Levels

Abstract

Myocardial infarction is among the related events in acute coronary syndrome, which also comprise unstable angina pectoris, ST-segment elevation myocardial infarction, and non-ST-segment elevation myocardial infarction. Objective: To determine the prevalence of multi-vessel coronary artery disease in non-ST-segment elevation myocardial infarction with observably increased troponin T concentrations. Methods: There were 284 patients participated in this research. Patients with cardiac troponin T concentrations above 500 ng/l (the recommended limit is 14 ng/l) who had previously had heart problems, tiredness, or other angina-related indications, regardless of gender, between the ages of 30 and 60, were also included in the research. Results: The study group consisted of 95 (33.46%) non-smokers and 189 (66.54%) smokers. Electrocardiogram alterations were detected in 179 (63.02%) participants, whereas no changes were detected in 105 (36.97%) individuals. Additionally, 113 individuals (39.78%) had multi-vessel coronary artery disease, compared to 171 (60.22%) who did not. Conclusion: We come to the conclusion that almost any person with elevated troponin T levels, despite the apparent absence of ST-segment elevation, may undergo cardiac catheterization to ascertain the diagnosis of multi-vessel coronary artery disease.

References

Vogel B, Claessen BE, Arnold SV, Chan D, Cohen DJ, Giannitsis E, et al. ST-segment elevation myocardial infarction. Nature reviews Disease primers. 2019 Jun; 5(1): 1-20. doi: 10.1038/s41572-019-0090-3

Wiviott SD, Antman EM, Gibson CM, Montalescot G, Riesmeyer J, Weerakkody G, et al. Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38). American heart journal. 2006 Oct; 152(4): 627-35. doi: 10.1016/j.ahj.2006.04.012

Gaziano TA, Bitton A, Anand S, Abrahams-Gessel S, Murphy A. Growing epidemic of coronary heart disease in low-and middle-income countries. Current problems in cardiology. 2010 Feb; 35(2): 72-115. doi: 10.1016/j.cpcardiol.2009.10.002

Chan MY, Sun JL, Newby LK, Shaw LK, Lin M, Peterson ED, et al. Long-term mortality of patients undergoing cardiac catheterization for ST-elevation and non-ST-elevation myocardial infarction. Circulation. 2009 Jun; 119(24): 3110-7. doi: 10.1161/CIRCULATIONAHA.108.799981

Guha S, Sethi R, Ray S, Bahl VK, Shanmugasundaram S, Kerkar P, et al. Cardiological Society of India: position statement for the management of ST elevation myocardial infarction in India. Indian heart journal. 2017 Apr; 69(1): S63-S97. doi: 10.1016/j.ihj.2017.03.006

Hashmi KA, Saeed HY, Farid MS, Najam J, Irfan M, Hashmi AA. Frequency of multivessel severe coronary artery disease in patients with non-ST segment elevation myocardial infarction having markedly raised cardiac troponin T. Cureus. 2020 Aug; 12(8). doi: 10.7759/cureus.9571

Abbas SH, Farooq AR, Nasir M, Khan MJ, Tariq U, Zafar H. Frequency Of Multivessel Severe Coronary Artery Disease In Patients With Non-ST Elevation Myocardial Infection. Journal of Pharmaceutical Negative Results. 2022 Nov: 3176-82..

Cavender MA, BA PH, MS MS. Outcomes of culprit versus multivessel PCI in patients with multivessel coronary artery disease presenting with ST-elevation myocardial infarction complicated by shock. Journal of Invasive Cardiology. 2013 Apr; 25(5): 218-24.

Zimarino M, Ricci F, Romanello M, Di Nicola M, Corazzini A, De Caterina R. Complete myocardial revascularization confers a larger clinical benefit when performed with state‐of‐the‐art techniques in high‐risk patients with multivessel coronary artery disease: A meta‐analysis of randomized and observational studies. Catheterization and Cardiovascular Interventions. 2016 Jan; 87(1): 3-12. doi: 10.1002/ccd.25923

Dangas G and Kuepper F. Restenosis: repeat narrowing of a coronary artery: prevention and treatment. Circulation. 2002 Jun; 105(22): 2586-7. doi: 10.1161/01.CIR.0000019122.00032.DF

Kelbæk H, Høfsten DE, Køber L, Helqvist S, Kløvgaard L, Holmvang L, et al. Deferred versus conventional stent implantation in patients with ST-segment elevation myocardial infarction (DANAMI 3-DEFER): an open-label, randomised controlled trial. The Lancet. 2016 May; 387(10034): 2199-206. doi: 10.1016/S0140-6736(16)30072-1

Procedure AF. Abstracts of the 64th Annual Conference of IACTS, February 2018. Indian Journal of Thoracic and Cardiovascular Surgery. 2018 June; 34(2): 181-331. doi: 10.1007/s12055-018-0649-8

Caputi CG, Ricci F, De Innocentiis C, De Caterina R, Zimarino M. Revascularization Strategies in Multivessel Coronary Artery Disease. Textbook of Catheter-Based Cardiovascular Interventions: A Knowledge-Based Approach. 2018: 881-900. doi: 10.1007/978-3-319-55994-0_53

Hashmi KA, Abbas K, Hashmi AA, Irfan M, Edhi MM, Ali N, et al. In-hospital mortality of patients with cardiogenic shock after acute myocardial infarction; impact of early revascularization. BMC research notes. 2018 Dec; 11(1): 1-5. doi: 10.1186/s13104-018-3830-7

Ottani F, Galvani M, Nicolini FA, Ferrini D, Pozzati A, Di Pasquale G, et al. Elevated cardiac troponin levels predict the risk of adverse outcome in patients with acute coronary syndromes. American heart journal. 2000 Dec; 140(6): 917-27. doi: 10.1067/mhj.2000.111107

Henrikson CA, Howell EE, Bush DE, Miles JS, Meininger GR, Friedlander T, et al. Prognostic usefulness of marginal troponin T elevation. The American journal of cardiology. 2004 Feb; 93(3): 275-9. doi: 10.1016/j.amjcard.2003.10.004

Sabatine MS, Morrow DA, McCabe CH, Antman EM, Gibson CM, Cannon CP. Combination of quantitative ST deviation and troponin elevation provides independent prognostic and therapeutic information in unstable angina and non-ST-elevation myocardial infarction. American Heart Journal. 2006 Jan; 151(1): 25-31. doi: 10.1016/j.ahj.2005.02.030

Hashmi KA, Shehzad A, Hashmi AA, Khan A. Atrioventricular block after acute myocardial infarction and its association with other clinical parameters in Pakistani patients: an institutional perspective. BMC Research Notes. 2018 Dec; 11(1): 1-4. doi: 10.1186/s13104-018-3431-5

Lakhani MS, Qadir F, Hanif B, Farooq S, Khan M. Correlation of thrombolysis in myocardial infarction (TIMI) risk score with extent of coronary artery disease in patients with acute coronary syndrome. Age (years). Journal Of Pakistan Medical Association. 2010 Mar; 56(9.69): 64-43.

Altmann DR, Mutschelknauss M, Ehl N, Koller M, Schaer B, Jörg L, et al. Prevalence of severely impaired left ventricular ejection fraction after reperfused ST-elevation myocardial infarction. Swiss medical weekly. 2013 Aug; 25(35). doi: 10.4414/smw.2013.13869

Qadir F, Farooq S, Khan M, Hanif B, Lakhani MS. Correlation of cardiac troponin I levels (10 folds upper limit of normal) and extent of coronary artery disease in non-ST elevation myocardial infarction. Journal Of Pakistan Medical Association. 2010 Jun; 60(6): 423-8.

Isilak Z, Kardesoglu E, Aparci M, Uz O, Yalcin M, Yiginer O, et al. Comparison of clinical risk assessment systems in predicting three− vessel coronary artery disease and angiographic culprit lesion in patients with non− ST segment elevated myocardial infarction/unstable angina pectoris. Polish Heart Journal. 2012; 70(3): 242-50.

Moses J, Doubell AF, Herbst PG, Weich HS, Klusmann KJ. Non-ST elevation myocardial infarction (NSTEMI) in three hospital settings in South Africa: does geography influence management and outcome? A retrospective cohort study: cardiovascular topics. Cardiovascular Journal of Africa. 2013 May; 24(4): 110-6. doi: 10.5830/CVJA-2013-017